Quanta Announces IND Clearance by U.S. FDA for QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, and Other Pipeline Updates by Seini Moimoi | Jan 8, 2025 | Portfolio News
Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc. by Seini Moimoi | Jan 8, 2025 | Portfolio News
Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round to Advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials by Seini Moimoi | Jan 7, 2025 | Portfolio News
